🌐 Nasdaq-listed healthcare innovator | $300M Ethereum treasury reserve | Compliance + transparency powering tomorrow’s balance sheets
United States
Joined October 2018
- Tweets816
- Following176
- Followers17.1K
- Likes434
Pinned Tweet
Robotic automation, smart logistics, and ongoing facility upgrades are fueling strong momentum at our pharmaceutical wholesale subsidiary, Cosmofarm, as record performance continues with accelerating customer growth, improving unit economics, and expanded delivery routes.
$COSM
@CosmosHealthInc CEO @GregSiokas issues letter to shareholders highlighting record 2026 revenue, U.S. subscription growth and global expansion.
$COSM
accessnewswire.com/newsroom/…
@CosmosHealthInc provides update on United States business
Active U.S. subscriptions up 42% from 6,287 to 8,940 in just 5 days
Q4 2026 U.S. revenue expected to reach $15 million, with gross profit of $10.5 million
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
In the 3 months since @CosmosHealthInc launched its U.S subscription model, we have reached 6,287 active subscriptions, the vast majority of them added since mid-September. As these subscriptions renew, we believe they can generate an attractive recurring revenue stream
$COSM 🇺🇸
@CosmosHealthInc reaches 6,287 active U.S. subscriptions, with 60.5% of online checkout orders including a subscription.
$COSM 🇺🇸
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
$COSM
Record day in our United States direct-to-consumer sales: we did over $92K in a single day.
$902K in 30 days. Daily average doubled to over $60K over the last 10 days.
We're executing and continue building on this momentum.
@CosmosHealthInc reports record single-day direct-to-consumer sales in the United States above $92,000, with $902,000 in sales over the past 30 days.
$COSM
accessnewswire.com/newsroom/…
@CosmosHealthInc reports record preliminary nine-month revenue of $54.3 million, up 19% year over year; delivers record Q3 revenue of $17.4 million and reaffirms 2026 revenue outlook of over $90 million.
$COSM
accessnewswire.com/newsroom/…
@CosmosHealthInc brands reach more than 40 countries across Europe, the Middle East, North America and Asia, addressing global markets estimated at approximately $946 billion
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
$COSM
CosmoFarm revenue is up 4.3x under @CosmosHealthInc ownership: from ~$14 million in fiscal 2017, the last full year before acquisition, to an annualized run-rate of over $60 million; ~330% growth at a CAGR of approximately 18%
@CosmosHealthInc CosmoFarm reaches record annualized revenue above $60 million; up 4.3x under Cosmos Health ownership, as robotics and AI build capacity to support over $100 million in annualized revenue.
$COSM #CosmosHealth #AI
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
$COSM Our contract manufacturing (CMO) division at Cana has become one of the most valuable parts of @CosmosHealthInc, surpassing $20M in implied revenue and $18M in implied gross profit across its record 32.7 million-unit production pipeline, under agreements averaging ~4 years.
@CosmosHealthInc contract manufacturing (CMO) division surpasses $20 million in implied revenue and $18 million in implied gross profit across its record 32.7 million-unit production pipeline.
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
$COSM is making solid progress. Every product launch. Every partnership. Reaching new markets. Our scientists, our R&D pipeline. Every late night with our team. All of it reminds me why we do this: a vision to elevate healthcare & create lasting value. We're just getting started
Cosmos Health Inc. (Nasdaq: COSM) retweeted
Cosmos Health $COSM secured orders of 7.7 million units in our CMO business this month alone. Our orderbook surged past 32.7 million units, up 31% since June, and close to threefold since the start of the year. That is a significant step change in the scale of this division.
@CosmosHealthInc Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
We have engaged Prime Ledger to structure an asset-specific, non-dilutive tokenized financing for our obesity product CCX0722 - backed by intellectual property, with no issuance of $COSM common stock - providing dedicated capital to support the program's continued development.
@CosmosHealthInc moves to tokenize CCX0722 intellectual property in innovative non-dilutive structure, eyes $562 billion weight-management market.
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
Securing an additional 2.5 million-unit order represents another important step in the continued expansion of our CMO business. With our cumulative orderbook now surpassing 27.5 million units, we are further strengthening the recurring cash flow profile of the division.
$COSM
@CosmosHealthInc secures additional 2.5 million units order under new five-year contract manufacturing agreement with Viofar.
Expands manufacturing presence in cardiovascular pharmaceuticals.
Total orderbook surpasses 27.5 million units.
$COSM
accessnewswire.com/newsroom/…
Cosmos Health Inc. (Nasdaq: COSM) retweeted
Earlier this year @CosmosHealthInc announced its entry into animal health, extending the C-Scrub franchise beyond human healthcare. Today sales have commenced in the United Kingdom under the brand name C-ScrubVet, with additional European markets to follow from Q4 2026.
$COSM